Clinical Approach to Recurrent Infections
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of recurrent infections
Recurrent infections represent a significant diagnostic challenge in clinical practice, affecting approximately 1 in 1,200 to 1 in 2,000 individuals when considering primary immunodeficiency disorders alone. Secondary immunodeficiency, caused by conditions such as HIV infection, malignancy, diabetes mellitus, and immunosuppressive therapy, is far more prevalent and accounts for the majority of cases seen in adult medicine. The evaluation of recurrent infections requires a systematic approach to distinguish normal infection frequency from pathological susceptibility, identify the underlying cause, and prevent complications including end-organ damage, bronchiectasis, and life-threatening sepsis.
Definition
Recurrent infections refer to repeated episodes of infection occurring more frequently than expected for a patient’s age, environment, and exposure history. Clinically significant recurrence is generally defined as two or more serious infections (such as pneumonia, meningitis, or sepsis) in one year, three or more respiratory infections (such as sinusitis, otitis, or bronchitis) in one year, or the need for prolonged antibiotic therapy to clear infections. The pattern, site, and causative organisms provide critical clues to the underlying immune defect.
Classification by Pattern of Recurrence
| Pattern | Definition | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute Recurrent | Discrete episodes with complete resolution between infections | Antibody deficiency, complement deficiency, anatomical defects | Suggests episodic failure of immune clearance; often amenable to prophylaxis |
| Chronic or Persistent | Infection that never fully clears despite appropriate therapy | T-cell defects, phagocyte disorders, biofilm-forming organisms | Indicates inability to eradicate pathogen; may require prolonged or combination therapy |
| Breakthrough | Infections occurring despite prophylactic antibiotics or immunoglobulin replacement | Inadequate prophylaxis dosing, resistant organisms, combined immune defects | Requires reassessment of prophylaxis regimen and search for additional defects |
Classification by Infection Site
Sinopulmonary Infections
The most common presentation of immunodeficiency. Recurrent sinusitis, otitis media, bronchitis, and pneumonia suggest antibody deficiency (particularly common variable immunodeficiency or selective immunoglobulin A deficiency). Progression to bronchiectasis indicates chronic immune impairment and is an important marker of delayed diagnosis.
Skin and Soft Tissue Infections
Recurrent abscesses, cellulitis, or impetigo may indicate phagocyte disorders (such as chronic granulomatous disease or leukocyte adhesion deficiency), hyper-immunoglobulin E syndrome, or neutropenia. Staphylococcal infections are particularly common in these conditions.
Gastrointestinal Infections
Chronic or recurrent diarrhea, especially with Giardia lamblia, Cryptosporidium, or Campylobacter, suggests antibody deficiency or T-cell dysfunction. Persistent oral candidiasis points toward T-cell or combined immunodeficiency.
Invasive or Systemic Infections
Meningitis, septicemia, osteomyelitis, or deep-seated abscesses represent the most serious presentations. Recurrent meningitis with encapsulated organisms (Streptococcus pneumoniae, Neisseria meningitidis) strongly suggests complement deficiency or asplenia.
Classification by Causative Organism
| Organism Type | Examples | Suggests Defect In |
|---|---|---|
| Encapsulated Bacteria | Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis | Antibody production, complement system, splenic function |
| Catalase-Positive Organisms | Staphylococcus aureus, Aspergillus species, Serratia marcescens, Burkholderia cepacia | Phagocyte oxidative burst (chronic granulomatous disease) |
| Opportunistic Fungi | Pneumocystis jirovecii, Candida species, Cryptococcus neoformans | T-cell immunity, combined immunodeficiency |
| Mycobacteria | Mycobacterium tuberculosis, non-tuberculous mycobacteria (Mycobacterium avium complex) | T-cell immunity, interferon-gamma/interleukin-12 pathway |
| Viruses (Severe or Prolonged) | Herpes simplex virus, cytomegalovirus, Epstein-Barr virus, varicella-zoster virus | T-cell immunity, natural killer cell function |
| Parasites | Giardia lamblia, Cryptosporidium, Toxoplasma gondii | Antibody deficiency (Giardia), T-cell immunity (others) |
Warning Signs of Primary Immunodeficiency
| Warning Sign | Description | Clinical Implication |
|---|---|---|
| Four or more ear infections in one year | Recurrent acute otitis media requiring antibiotics | Suggests antibody deficiency, particularly in adults where this is uncommon |
| Two or more serious sinus infections in one year | Bacterial sinusitis requiring prolonged antibiotics | Common presentation of common variable immunodeficiency |
| Two or more pneumonias in one year | Radiographically confirmed pneumonia | High suspicion for immunodeficiency; warrants full workup |
| Two or more months on antibiotics with little effect | Persistent infection despite appropriate therapy | Indicates impaired pathogen clearance |
| Need for intravenous antibiotics to clear infections | Failure of oral therapy requiring escalation | Suggests more severe immune compromise |
| Two or more deep-seated infections | Meningitis, osteomyelitis, septicemia, cellulitis | Serious infections mandate thorough immune evaluation |
| Recurrent deep skin or organ abscesses | Abscesses in liver, lung, lymph nodes, or perirectal area | Classic for chronic granulomatous disease or hyper-immunoglobulin E syndrome |
| Persistent thrush or fungal skin infections | Candidiasis beyond infancy or after antibiotics | T-cell defects, diabetes mellitus, HIV infection |
| Family history of immunodeficiency | Known primary immunodeficiency in relatives | Many primary immunodeficiencies have genetic inheritance patterns |
Key Concept: The “SPUR” Infections
When evaluating recurrent infections, consider whether they are:
- Severe — requiring hospitalization or intravenous therapy
- Persistent — failing to clear with standard treatment duration
- Unusual — caused by opportunistic or uncommon organisms
- Recurrent — occurring repeatedly at the same or multiple sites
The presence of any SPUR characteristic should prompt consideration of an underlying immunodeficiency or predisposing condition.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of recurrent infections
The immune system provides layered defense against pathogens through innate and adaptive mechanisms. Understanding these components is essential for interpreting the pattern of recurrent infections and identifying the specific defect. The innate immune system provides immediate, non-specific defense through physical barriers, complement proteins, phagocytes, and natural killer cells. The adaptive immune system generates specific responses through T lymphocytes and B lymphocytes, with the latter producing antibodies. Defects at any level result in characteristic infection patterns that guide diagnostic evaluation.
Components of Host Defense
| Component | Key Elements | Primary Function |
|---|---|---|
| Physical Barriers | Skin, mucous membranes, cilia, gastric acid, urinary flow | Prevent pathogen entry; first line of defense |
| Complement System | Classical, alternative, and lectin pathways; membrane attack complex | Opsonization, direct lysis of pathogens, inflammation |
| Phagocytes | Neutrophils, monocytes, macrophages, dendritic cells | Engulf and destroy pathogens; antigen presentation |
| Natural Killer Cells | Innate lymphoid cells with cytotoxic function | Kill virus-infected cells and tumor cells without prior sensitization |
| T Lymphocytes | CD4+ helper T cells, CD8+ cytotoxic T cells, regulatory T cells | Coordinate immune responses; kill infected cells; regulate immunity |
| B Lymphocytes | Antibody-producing cells; plasma cells; memory B cells | Produce immunoglobulins (IgG, IgA, IgM, IgE) for pathogen neutralization and opsonization |
Immunoglobulin Classes and Their Functions
Immunoglobulin G
Location: Serum (most abundant)
Function: Opsonization, complement activation, neutralization; crosses placenta
Deficiency pattern: Recurrent sinopulmonary infections with encapsulated bacteria
Immunoglobulin A
Location: Mucosal surfaces, secretions
Function: Mucosal immunity; prevents pathogen adherence
Deficiency pattern: Often asymptomatic; may have respiratory and gastrointestinal infections
Immunoglobulin M
Location: Serum, B-cell surface
Function: Primary immune response; complement activation
Deficiency pattern: Susceptibility to bloodstream infections with encapsulated bacteria
Mechanisms of Primary Immunodeficiency
| Category | Example Conditions | Mechanism | Characteristic Infections |
|---|---|---|---|
| Antibody Deficiencies | Common variable immunodeficiency, X-linked agammaglobulinemia, selective immunoglobulin A deficiency | Defective B-cell development or function; inadequate antibody production | Encapsulated bacteria (Streptococcus pneumoniae, Haemophilus influenzae); Giardia; enteroviruses |
| Combined Immunodeficiencies | Severe combined immunodeficiency, combined variable immunodeficiency | Defects in both T-cell and B-cell function; often genetic mutations affecting lymphocyte development | Opportunistic infections (Pneumocystis jirovecii, cytomegalovirus, Candida); failure to thrive in infancy |
| Phagocyte Defects | Chronic granulomatous disease, leukocyte adhesion deficiency, cyclic neutropenia | Impaired oxidative burst (chronic granulomatous disease) or migration (leukocyte adhesion deficiency); reduced phagocyte numbers | Catalase-positive organisms (Staphylococcus aureus, Aspergillus, Serratia); deep abscesses; poor wound healing |
| Complement Deficiencies | C3 deficiency, terminal complement (C5-C9) deficiency, mannose-binding lectin deficiency | Impaired opsonization (early components) or membrane attack complex formation (terminal components) | Encapsulated bacteria; recurrent Neisseria infections (meningococcal meningitis) with terminal defects |
| Innate Immunity Defects | Toll-like receptor defects, interleukin-12/interferon-gamma pathway defects, natural killer cell deficiency | Impaired pathogen recognition or cytokine signaling | Mycobacterial infections (interleukin-12/interferon-gamma defects); herpesvirus infections (natural killer cell defects) |
Mechanisms of Secondary Immunodeficiency
| Cause | Mechanism | Resulting Immune Defect | Common Infections |
|---|---|---|---|
| HIV Infection | Progressive CD4+ T-cell depletion; impaired cell-mediated immunity | T-cell deficiency leading to combined defect | Pneumocystis jirovecii, Mycobacterium avium complex, cytomegalovirus, Cryptococcus, Toxoplasma |
| Diabetes Mellitus | Impaired neutrophil chemotaxis and phagocytosis; hyperglycemia promotes bacterial growth | Phagocyte dysfunction | Skin and soft tissue infections, urinary tract infections, mucormycosis, malignant otitis externa |
| Chronic Kidney Disease | Uremia impairs T-cell and phagocyte function; dialysis-related factors | Combined cellular and humoral dysfunction | Bacterial infections (especially vascular access-related), tuberculosis |
| Malignancy | Tumor-induced immunosuppression; treatment effects (chemotherapy, radiation) | Variable depending on malignancy type and treatment | Bacterial infections during neutropenia; opportunistic infections with prolonged lymphopenia |
| Immunosuppressive Therapy | Corticosteroids (broad immunosuppression), biologics (targeted pathway inhibition) | Depends on agent: T-cell suppression, B-cell depletion, cytokine blockade | Opportunistic infections; reactivation of latent infections (tuberculosis, hepatitis B) |
| Asplenia | Loss of splenic filtration and opsonin production; impaired response to encapsulated bacteria | Defective clearance of encapsulated organisms | Overwhelming post-splenectomy infection (Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis) |
| Malnutrition | Protein-energy malnutrition impairs lymphocyte function and mucosal barrier integrity | Combined T-cell and barrier dysfunction | Respiratory infections, diarrheal illness, tuberculosis |
Anatomical and Local Factors
Structural Abnormalities
- Bronchiectasis: Dilated airways with impaired mucociliary clearance promote bacterial colonization
- Urinary tract abnormalities: Vesicoureteral reflux, obstruction, or neurogenic bladder cause recurrent urinary tract infections
- Sinus abnormalities: Polyps, septal deviation, or ostial obstruction impair drainage
- Cerebrospinal fluid leaks: Skull base defects allow direct bacterial access to meninges
Foreign Bodies and Devices
- Central venous catheters: Biofilm formation leads to catheter-related bloodstream infections
- Prosthetic joints and hardware: Biofilm-associated infections are difficult to eradicate
- Urinary catheters: Bypass normal defense mechanisms; promote ascending infection
- Endotracheal tubes: Impair cough reflex and mucociliary clearance
Why Specific Organisms Cause Infections in Specific Defects
| Immune Component | Defense Against | When Deficient, Susceptible To | Clinical Example |
|---|---|---|---|
| Antibodies | Extracellular bacteria, especially encapsulated organisms | Streptococcus pneumoniae, Haemophilus influenzae, Giardia lamblia | Patient with common variable immunodeficiency develops recurrent pneumococcal pneumonia |
| Complement (Terminal) | Neisseria species (require membrane attack complex for killing) | Recurrent Neisseria meningitidis, Neisseria gonorrhoeae | Young adult with second episode of meningococcal meningitis |
| Neutrophil Oxidative Burst | Catalase-positive organisms (which destroy their own hydrogen peroxide) | Staphylococcus aureus, Aspergillus, Serratia, Burkholderia, Nocardia | Child with chronic granulomatous disease develops hepatic Staphylococcus aureus abscess |
| CD4+ T Cells | Intracellular pathogens requiring cell-mediated immunity | Pneumocystis jirovecii, Mycobacterium avium complex, Cryptococcus, Toxoplasma | HIV patient with CD4 count less than 200 cells per microliter develops Pneumocystis pneumonia |
| Interferon-Gamma/Interleukin-12 Pathway | Mycobacteria, Salmonella (require macrophage activation) | Disseminated non-tuberculous mycobacteria, BCG disease, Salmonella | Child develops disseminated Mycobacterium avium complex infection after routine vaccination |
| Spleen | Blood-borne encapsulated bacteria | Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis | Post-splenectomy patient develops fulminant pneumococcal sepsis |
Often Overlooked Mechanism
Protein-losing states: Conditions causing loss of immunoglobulins—such as nephrotic syndrome, protein-losing enteropathy, and severe burns—can result in secondary antibody deficiency and recurrent infections with encapsulated bacteria. Always check serum albumin and consider urinary protein loss in patients with unexplained hypogammaglobulinemia. Similarly, intestinal lymphangiectasia can cause profound lymphopenia and hypogammaglobulinemia through loss of lymphocytes and immunoglobulins into the gut.
3. History Taking
A comprehensive approach to eliciting the recurrent infection history
Red Flags — Require Urgent Evaluation
- Two or more episodes of meningitis or sepsis — Suggests complement deficiency, asplenia, or severe immunodeficiency
- Invasive infection with opportunistic organism — Pneumocystis jirovecii, Cryptococcus, or disseminated mycobacteria indicate severe T-cell defect
- Failure to thrive or chronic diarrhea with infections — Combined immunodeficiency or HIV infection
- Recurrent deep-seated abscesses — Chronic granulomatous disease or hyper-immunoglobulin E syndrome
- Family history of early death from infection — Primary immunodeficiency with genetic inheritance
- Disseminated BCG infection or severe reaction to live vaccines — Severe combined immunodeficiency or interferon-gamma pathway defect
- Unexplained weight loss greater than 10% — HIV infection, malignancy, or chronic infection
- Recurrent Neisseria infections — Terminal complement deficiency
Systematic History: The “DEFEND” Approach
Use the mnemonic “DEFEND” to ensure comprehensive history taking for recurrent infections:
- D — Description of infections: What types of infections? Which sites? What organisms were isolated? How severe were they? Did they require hospitalization or intravenous antibiotics?
- E — Episodes and timeline: How many infections? Over what time period? Age at first unusual infection? Complete resolution between episodes or persistent symptoms?
- F — Family history: Any relatives with recurrent infections, early death from infection, autoimmune disease, or known immunodeficiency? Consanguinity?
- E — Exposures and environment: Occupational exposures? Travel history? Animal contacts? Sick contacts? Smoking? Institutional living?
- N — Non-immune causes: Anatomical abnormalities? Foreign bodies or devices? Structural lung disease? Urinary obstruction? Cerebrospinal fluid leak?
- D — Drugs and diseases: Immunosuppressive medications? Underlying conditions (HIV, diabetes, malignancy, renal failure)? Previous chemotherapy or radiation?
Characterizing the Infection Pattern
| Question | Why It Matters | What the Answer Suggests |
|---|---|---|
| “What types of infections have you had?” | Different immune defects cause different infection patterns | Sinopulmonary infections suggest antibody deficiency; skin abscesses suggest phagocyte defect; opportunistic infections suggest T-cell defect |
| “What organisms were identified?” | Organism type correlates with immune defect | Encapsulated bacteria suggest antibody or complement deficiency; catalase-positive organisms suggest chronic granulomatous disease; fungi and viruses suggest T-cell defect |
| “How old were you when infections started?” | Age of onset helps distinguish primary from secondary causes | Infancy suggests severe combined immunodeficiency or phagocyte defect; after age 6 months suggests antibody deficiency (maternal antibodies wane); adulthood suggests secondary cause or common variable immunodeficiency |
| “Do infections clear completely with treatment?” | Persistent infection indicates inability to eradicate pathogen | Complete resolution suggests episodic susceptibility; persistence suggests phagocyte defect or biofilm-associated infection |
| “Have you needed intravenous antibiotics or hospitalization?” | Severity indicates degree of immune compromise | Severe infections requiring intensive treatment are more concerning for significant immunodeficiency |
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Common variable immunodeficiency | Recurrent sinopulmonary infections, autoimmune disease, gastrointestinal symptoms | “Have you had any autoimmune conditions like low platelets, anemia, or thyroid problems? Do you have chronic diarrhea or unexplained weight loss?” |
| Selective immunoglobulin A deficiency | Often asymptomatic; respiratory and gastrointestinal infections; autoimmunity; allergies | “Have you ever had a reaction to a blood transfusion? Do you have celiac disease or other autoimmune conditions?” |
| Complement deficiency | Recurrent Neisseria infections; systemic lupus erythematosus-like illness with early complement defects | “Have you had meningitis more than once? Have you had unusual problems with Neisseria bacteria, including gonorrhea that was hard to treat?” |
| Chronic granulomatous disease | Deep abscesses (liver, lung, lymph nodes); osteomyelitis; granuloma formation | “Have you had abscesses in your liver or lungs? Have you had bone infections or unusual granulomas found on imaging or biopsy?” |
| HIV infection | Opportunistic infections; weight loss; oral candidiasis; Kaposi sarcoma | “Have you ever been tested for HIV? Have you had any risk factors such as unprotected sexual contact or injection drug use?” |
| Asplenia or hyposplenism | History of splenectomy or splenic dysfunction; overwhelming sepsis with encapsulated organisms | “Have you had your spleen removed? Do you have sickle cell disease or have you had radiation to your abdomen?” |
| Diabetes mellitus | Recurrent skin infections, urinary tract infections, fungal infections | “Do you have diabetes? How well controlled is your blood sugar? Have you had recurrent yeast infections or foot infections?” |
| Anatomical abnormality | Infections at single site; bronchiectasis; urinary tract abnormalities | “Are all your infections in the same location? Have you had any surgery or trauma to that area? Have you had imaging of the affected site?” |
Medication and Immunosuppression History
Medications Causing Immunosuppression
- Corticosteroids: Doses greater than 20 mg prednisone daily for more than 2 weeks cause significant immunosuppression; risk of Pneumocystis jirovecii, reactivation of tuberculosis and herpes viruses
- Tumor necrosis factor inhibitors: Infliximab, adalimumab, etanercept — risk of tuberculosis reactivation, invasive fungal infections
- Rituximab: B-cell depletion causes hypogammaglobulinemia; risk persists for months after treatment
- Methotrexate and azathioprine: Bone marrow suppression; opportunistic infections
- Calcineurin inhibitors: Cyclosporine, tacrolimus — T-cell suppression; opportunistic infections in transplant recipients
- Chemotherapy: Neutropenia and lymphopenia; risk depends on regimen intensity
- JAK inhibitors: Tofacitinib, baricitinib — herpes zoster reactivation, opportunistic infections
Social and Environmental History
- Smoking: Impairs mucociliary clearance; increases risk of respiratory infections and bronchiectasis
- Occupation: Healthcare workers (tuberculosis exposure); agricultural workers (fungal infections); daycare workers (frequent viral exposures)
- Travel: Endemic mycoses (histoplasmosis, coccidioidomycosis); tuberculosis in high-prevalence areas; tropical parasites
- Sexual history: HIV risk factors; recurrent sexually transmitted infections may indicate immunodeficiency
- Injection drug use: HIV, hepatitis B and C; endocarditis; skin and soft tissue infections
- Living conditions: Congregate settings increase exposure; homelessness associated with tuberculosis
- Animal contacts: Cats (Bartonella, Toxoplasma); birds (Cryptococcus, Histoplasma); reptiles (Salmonella)
Family History Assessment
| Family History Finding | Suggests | Inheritance Pattern |
|---|---|---|
| Male relatives dying in infancy from infection | X-linked severe combined immunodeficiency, X-linked agammaglobulinemia, chronic granulomatous disease | X-linked recessive |
| Consanguinity with affected siblings | Autosomal recessive immunodeficiency | Autosomal recessive |
| Multiple generations affected | Common variable immunodeficiency, complement deficiency, hyper-immunoglobulin E syndrome | Autosomal dominant or variable |
| Autoimmune disease in family | Common variable immunodeficiency, selective immunoglobulin A deficiency (often associated with autoimmunity) | Variable |
| Early death from overwhelming infection | Asplenia, complement deficiency, severe combined immunodeficiency | Variable depending on condition |
Vaccination History
Why Vaccination History Matters
Vaccination history provides important diagnostic and safety information:
- Adverse reactions to live vaccines: Disseminated BCG, vaccine-strain polio, or severe varicella after vaccination suggests severe T-cell deficiency or combined immunodeficiency
- Failure to respond to vaccines: Breakthrough infections despite vaccination suggests antibody deficiency; can be formally assessed with vaccine response titers
- Missing vaccinations: Patients with suspected immunodeficiency should not receive live vaccines until evaluated; document which vaccines were given
4. Physical Examination
A systematic head-to-toe approach for recurrent infections
Dual Purpose Examination: The physical examination in recurrent infections serves two purposes: (1) identifying signs of the current or recent infection, and (2) detecting clues to the underlying cause of immune dysfunction. Use the “Head to Extremities” approach while specifically looking for stigmata of immunodeficiency and end-organ damage from chronic infection.
General Inspection
- General appearance: Cachexia or failure to thrive suggests chronic illness, HIV, or malignancy; cushingoid features suggest corticosteroid use
- Nutritional status: Malnutrition impairs immunity; assess muscle wasting and subcutaneous fat
- Skin color: Pallor (anemia from chronic disease or marrow failure); jaundice (hepatic involvement); hyperpigmentation (Addison disease with autoimmune polyendocrinopathy)
- Dysmorphic features: Specific syndromes associated with immunodeficiency (DiGeorge syndrome, ataxia-telangiectasia, Wiskott-Aldrich syndrome)
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Temperature | Fever, hypothermia, or afebrile despite active infection | Hypothermia or absence of fever with infection may indicate impaired inflammatory response (neutropenia, advanced immunodeficiency); low-grade fever suggests chronic infection |
| Heart Rate | Tachycardia, irregularity | Tachycardia out of proportion to fever suggests sepsis or significant infection; resting tachycardia may indicate chronic illness |
| Blood Pressure | Hypotension, orthostatic changes | Hypotension suggests sepsis or adrenal insufficiency (autoimmune polyendocrinopathy); orthostatic changes indicate volume depletion |
| Respiratory Rate | Tachypnea, increased work of breathing | May indicate pneumonia or chronic lung disease from recurrent infections; Pneumocystis jirovecii pneumonia often presents with marked tachypnea |
| Oxygen Saturation | Hypoxemia at rest or with exertion | Hypoxemia with relatively clear chest radiograph is classic for Pneumocystis jirovecii pneumonia; chronic hypoxemia suggests bronchiectasis |
Head, Eyes, Ears, Nose, and Throat Examination
Oral Cavity
- Oral candidiasis (thrush): White plaques on buccal mucosa and tongue; suggests T-cell deficiency, diabetes, or recent antibiotic use
- Oral ulcers: May indicate cyclic neutropenia (recurrent aphthous ulcers timed with neutropenic nadirs) or HIV
- Gingivitis and periodontitis: Severe disease suggests neutrophil defects; common in chronic granulomatous disease and leukocyte adhesion deficiency
- Absent or small tonsils: May indicate X-linked agammaglobulinemia (B cells absent, so lymphoid tissue reduced)
- Oral hairy leukoplakia: White patches on lateral tongue; pathognomonic for HIV infection
Eyes, Ears, and Sinuses
- Conjunctival telangiectasias: Characteristic of ataxia-telangiectasia
- Tympanic membrane scarring: Evidence of recurrent otitis media
- Nasal polyps: Associated with cystic fibrosis and chronic sinusitis; may indicate mucosal immune dysfunction
- Sinus tenderness: Suggests active sinusitis; chronic tenderness indicates recurrent or persistent infection
- Post-nasal drip: Mucopurulent discharge suggests chronic sinusitis
Lymphoid Tissue Assessment
| Finding | Description | Clinical Significance |
|---|---|---|
| Absent lymph nodes and tonsils | No palpable lymph nodes; small or absent tonsillar tissue | Suggests X-linked agammaglobulinemia (absent B cells) or severe combined immunodeficiency |
| Generalized lymphadenopathy | Enlarged lymph nodes in multiple regions | Common variable immunodeficiency (granulomatous disease), HIV infection, lymphoma, chronic infection |
| Splenomegaly | Palpable spleen below left costal margin | Common variable immunodeficiency, HIV, chronic infection, lymphoproliferative disease; may be absent in asplenia |
| Absent spleen | No splenic dullness to percussion; Howell-Jolly bodies on blood smear | Surgical asplenia, functional asplenia (sickle cell disease), or congenital asplenia |
| Hepatomegaly | Liver palpable below right costal margin | Hepatic abscess (chronic granulomatous disease), chronic infection, or lymphoproliferative infiltration |
Skin and Soft Tissue Examination
| Finding | Description | Associated Conditions |
|---|---|---|
| Eczematous dermatitis | Severe, widespread eczema often with secondary infection | Hyper-immunoglobulin E syndrome, Wiskott-Aldrich syndrome, IPEX syndrome |
| Recurrent or chronic abscesses | Boils, furuncles, or deeper abscesses; poor healing | Chronic granulomatous disease, hyper-immunoglobulin E syndrome, neutrophil defects |
| Telangiectasias | Small dilated blood vessels on skin and mucous membranes | Ataxia-telangiectasia (conjunctivae, ears, neck); hereditary hemorrhagic telangiectasia |
| Petechiae and purpura | Non-blanching red or purple spots | Thrombocytopenia (Wiskott-Aldrich syndrome, immune thrombocytopenia in common variable immunodeficiency); vasculitis |
| Kaposi sarcoma | Purple or brown nodules or plaques | HIV infection with advanced immunosuppression |
| Molluscum contagiosum (extensive) | Multiple umbilicated papules; widespread distribution | T-cell deficiency; common in HIV with low CD4 counts |
| Warts (extensive or recalcitrant) | Multiple warts that persist despite treatment | WHIM syndrome, DOCK8 deficiency, other T-cell disorders |
| Skin abscesses with poor pus formation | “Cold abscesses” — fluctuant masses without surrounding erythema or warmth | Hyper-immunoglobulin E syndrome; inability to form adequate inflammatory response |
Respiratory Examination
Inspection
- Chest wall deformity: Harrison sulcus or pectus deformities from chronic respiratory disease
- Increased anteroposterior diameter: Air trapping from chronic lung disease
- Digital clubbing: Indicates chronic suppurative lung disease, bronchiectasis, or lung abscess
- Use of accessory muscles: Suggests respiratory distress or chronic lung disease
Auscultation
| Finding | Description | Clinical Significance |
|---|---|---|
| Crackles (localized) | Coarse crackles in one area | Pneumonia, localized bronchiectasis |
| Crackles (bilateral) | Crackles heard throughout both lung fields | Diffuse bronchiectasis, interstitial lung disease (common in common variable immunodeficiency), Pneumocystis jirovecii pneumonia |
| Wheeze | High-pitched expiratory sounds | Asthma (common comorbidity); bronchiectasis; endobronchial lesion if localized |
| Bronchial breath sounds | Harsh breath sounds heard over peripheral lung | Consolidation from pneumonia |
| Decreased breath sounds | Diminished air entry in a region | Pleural effusion, empyema, lung abscess |
Neurological Examination
- Ataxia: Cerebellar ataxia is characteristic of ataxia-telangiectasia; progressive and may precede infections
- Cognitive impairment: May indicate chronic meningoencephalitis, progressive multifocal leukoencephalopathy (HIV), or prior central nervous system infection
- Peripheral neuropathy: Can occur with HIV, chronic inflammatory demyelinating polyneuropathy (associated with common variable immunodeficiency)
- Focal deficits: May indicate brain abscess (chronic granulomatous disease, nocardiosis) or central nervous system lymphoma (HIV)
Musculoskeletal Examination
- Arthritis: May be septic (immunodeficiency) or autoimmune (common variable immunodeficiency, selective immunoglobulin A deficiency)
- Coarse facial features: Hyper-immunoglobulin E syndrome (Job syndrome) presents with characteristic facies
- Scoliosis and pathologic fractures: Hyper-immunoglobulin E syndrome affects connective tissue; recurrent fractures are common
- Retained primary teeth: Failure of primary teeth to exfoliate is seen in hyper-immunoglobulin E syndrome
Expected Findings by Underlying Cause
| Condition | General Appearance | Key Physical Findings | Other Clues |
|---|---|---|---|
| Common variable immunodeficiency | Often normal; may have cachexia if chronic infection | Splenomegaly, lymphadenopathy, bronchiectasis signs | May have associated autoimmune disease findings |
| X-linked agammaglobulinemia | Young male; may appear well between infections | Absent tonsils and lymph nodes; no splenomegaly | Small for age if severe; chronic lung disease |
| Chronic granulomatous disease | May have failure to thrive; hepatomegaly | Lymphadenopathy, hepatosplenomegaly, skin abscesses, perianal disease | Scars from prior abscesses and surgeries |
| Hyper-immunoglobulin E syndrome | Coarse facial features; eczematous skin | Cold abscesses, severe eczema, retained primary teeth, scoliosis | Characteristic facies with broad nose, deep-set eyes |
| HIV infection | Cachexia, lymphadenopathy | Oral candidiasis, oral hairy leukoplakia, Kaposi sarcoma, seborrheic dermatitis | Generalized lymphadenopathy, hepatosplenomegaly |
| Complement deficiency | Often normal between infections | Usually normal examination; may have signs of current infection | May have lupus-like rash with early complement defects |
| Ataxia-telangiectasia | Progressive neurological decline | Cerebellar ataxia, oculocutaneous telangiectasias, choreoathetosis | Telangiectasias on conjunctivae, ears, neck, antecubital fossae |
Important Teaching Point
Normal examination is common! Many patients with significant immunodeficiency, particularly antibody deficiencies like common variable immunodeficiency, selective immunoglobulin A deficiency, and complement deficiencies, may have entirely normal physical examination findings between infections. The history of infection pattern is often more informative than the physical examination. Additionally, patients with neutropenia or severe T-cell deficiency may fail to mount an adequate inflammatory response, so infections may present with minimal physical findings (absence of pus, absence of lymphadenopathy, minimal fever).
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
Step-by-Step Approach to Recurrent Infections:
- Step 1: Confirm that infections are truly abnormal — Consider normal frequency for age and exposures; rule out recurrent symptoms without true infection
- Step 2: Exclude secondary causes — HIV testing, diabetes screening, medication review, malignancy workup if indicated
- Step 3: Identify anatomical or local factors — Imaging of recurrently infected sites; assess for foreign bodies or structural abnormalities
- Step 4: Evaluate for primary immunodeficiency — Guided by infection pattern, organism type, and age of onset
Secondary Causes of Recurrent Infections (Most Common in Adults)
| Probability | Condition | Key Features | Diagnostic Clues |
|---|---|---|---|
| COMMON | Diabetes mellitus | Skin and soft tissue infections, urinary tract infections, candidiasis, malignant otitis externa | Polyuria, polydipsia; elevated glucose; recurrent fungal infections |
| COMMON | HIV infection | Opportunistic infections, oral candidiasis, weight loss, lymphadenopathy | Risk factors present; declining CD4 count; opportunistic organisms |
| COMMON | Iatrogenic immunosuppression | Infections correlate with medication use; opportunistic organisms; reactivation of latent infections | History of corticosteroids, biologics, chemotherapy, transplant medications |
| COMMON | Anatomical abnormalities | Infections localized to one site; bronchiectasis; urinary tract obstruction; cerebrospinal fluid leak | Single site of recurrence; abnormal imaging; history of trauma or surgery |
| LESS COMMON | Malignancy (hematologic) | Chronic lymphocytic leukemia, multiple myeloma, lymphoma | Hypogammaglobulinemia; abnormal complete blood count; lymphadenopathy; monoclonal protein |
| LESS COMMON | Chronic kidney disease | Urinary tract infections, respiratory infections, dialysis access infections | Elevated creatinine; uremia; dialysis dependence |
| LESS COMMON | Cirrhosis and liver disease | Spontaneous bacterial peritonitis, respiratory infections, bacteremia | Ascites; coagulopathy; elevated bilirubin; spider angiomata |
| LESS COMMON | Asplenia or hyposplenism | Overwhelming sepsis with encapsulated organisms; rapid deterioration | History of splenectomy; sickle cell disease; Howell-Jolly bodies on smear |
| UNCOMMON | Nephrotic syndrome | Infections with encapsulated bacteria; peritonitis; cellulitis | Massive proteinuria; hypoalbuminemia; edema; urinary immunoglobulin loss |
| UNCOMMON | Protein-losing enteropathy | Hypogammaglobulinemia with gastrointestinal symptoms | Diarrhea; hypoalbuminemia; elevated stool alpha-1 antitrypsin |
Primary Immunodeficiencies by Category
Antibody Deficiencies (Most Common Primary Immunodeficiency in Adults)
| Condition | Prevalence | Age of Onset | Key Features |
|---|---|---|---|
| Common variable immunodeficiency | 1 in 25,000 to 1 in 50,000 | Second to fourth decade (bimodal) | Recurrent sinopulmonary infections; autoimmune disease (20-25%); granulomatous disease; increased malignancy risk; bronchiectasis; splenomegaly |
| Selective immunoglobulin A deficiency | 1 in 300 to 1 in 700 (most common) | Any age; often incidental finding | Often asymptomatic; respiratory and gastrointestinal infections; autoimmune disease; allergies; anaphylaxis to blood products containing immunoglobulin A |
| Specific antibody deficiency | Unknown; likely underdiagnosed | Childhood to adulthood | Normal immunoglobulin levels but poor response to polysaccharide vaccines; recurrent sinopulmonary infections |
| Immunoglobulin G subclass deficiency | Variable | Any age | Low IgG2 or IgG3 with recurrent infections; controversial clinical significance without functional antibody deficiency |
| X-linked agammaglobulinemia | 1 in 200,000 males | After 6 months (maternal antibodies wane) | Males only; absent B cells and immunoglobulins; absent tonsils and lymph nodes; recurrent bacterial infections; enteroviral meningoencephalitis |
Combined Immunodeficiencies
| Condition | Key Features | Characteristic Infections |
|---|---|---|
| Severe combined immunodeficiency | Presents in infancy; failure to thrive; absent thymic shadow; lymphopenia | Pneumocystis jirovecii, cytomegalovirus, Candida; disseminated BCG; fatal if untreated |
| DiGeorge syndrome (22q11.2 deletion) | Cardiac defects, hypocalcemia, facial dysmorphism; thymic hypoplasia | Variable T-cell deficiency; may have mild to severe infections depending on thymic function |
| Wiskott-Aldrich syndrome | Males; eczema, thrombocytopenia with small platelets, immunodeficiency | Encapsulated bacteria, Pneumocystis jirovecii, herpesviruses |
| Ataxia-telangiectasia | Progressive cerebellar ataxia; oculocutaneous telangiectasias; elevated alpha-fetoprotein | Sinopulmonary infections; bronchiectasis; increased malignancy risk |
Phagocyte Defects
| Condition | Mechanism | Characteristic Features |
|---|---|---|
| Chronic granulomatous disease | Defective NADPH oxidase; impaired oxidative burst | Catalase-positive organisms (Staphylococcus aureus, Aspergillus, Serratia, Burkholderia); deep abscesses (liver, lung, lymph nodes); granuloma formation; inflammatory bowel disease-like illness |
| Leukocyte adhesion deficiency | Defective leukocyte migration; absent CD18 | Delayed umbilical cord separation; severe periodontitis; skin infections without pus formation; very high neutrophil counts |
| Cyclic neutropenia | Regular 21-day cycles of neutropenia | Fever, mouth ulcers, and infections recurring every 3 weeks; infections during neutropenic nadir |
| Severe congenital neutropenia | Maturation arrest of neutrophil precursors | Severe infections from infancy; absolute neutrophil count typically less than 500 cells per microliter |
Complement Deficiencies
| Component | Infection Susceptibility | Other Associations |
|---|---|---|
| C1, C2, C4 deficiency (early classical pathway) | Encapsulated bacteria (less severe than C3 deficiency) | Systemic lupus erythematosus and lupus-like illness (especially C2 and C4 deficiency) |
| C3 deficiency | Severe recurrent infections with encapsulated bacteria; pyogenic infections | Glomerulonephritis; most severe complement deficiency for infections |
| C5-C9 deficiency (terminal complement/membrane attack complex) | Recurrent Neisseria infections (meningococcal meningitis, disseminated gonococcal infection) | Often healthy otherwise; 5,000 to 10,000-fold increased risk of meningococcal disease |
| Mannose-binding lectin deficiency | Increased infections in first few years of life; generally mild in adults | Very common (5-10% of population); clinical significance controversial |
| Properdin deficiency | Fulminant meningococcal disease | X-linked; often fatal first episode of meningococcal infection |
Approach by Immune Defect Category
Antibody Deficiency
Encapsulated bacteria
Giardia lamblia
Enteroviruses
Sinopulmonary infections
Bronchiectasis
T-Cell/Combined Deficiency
Pneumocystis jirovecii
Cytomegalovirus
Candida species
Mycobacteria
Cryptococcus
Phagocyte Defects
Staphylococcus aureus
Aspergillus species
Serratia marcescens
Burkholderia cepacia
Deep abscesses
Complement Deficiency
Neisseria meningitidis
Neisseria gonorrhoeae
Streptococcus pneumoniae
Haemophilus influenzae
Recurrent meningitis
Drug-Induced Immunosuppression
| Drug or Drug Class | Mechanism of Immunosuppression | Characteristic Infections | Time to Immune Recovery |
|---|---|---|---|
| Corticosteroids (high dose) | Broad immunosuppression; impaired T-cell function, neutrophil migration, and cytokine production | Pneumocystis jirovecii, Aspergillus, reactivation tuberculosis, Strongyloides hyperinfection, herpes zoster | Weeks after discontinuation; depends on dose and duration |
| Tumor necrosis factor inhibitors | Impaired granuloma formation and maintenance; T-cell dysfunction | Reactivation tuberculosis, invasive fungal infections (histoplasmosis, coccidioidomycosis), Listeria | Variable; weeks to months depending on half-life |
| Rituximab | B-cell depletion; secondary hypogammaglobulinemia | Bacterial infections (sinopulmonary); progressive multifocal leukoencephalopathy; hepatitis B reactivation | 6 to 12 months for B-cell recovery; immunoglobulin may remain low longer |
| Calcineurin inhibitors (cyclosporine, tacrolimus) | T-cell suppression via inhibition of interleukin-2 production | Opportunistic infections typical of T-cell defects; BK virus nephropathy | Days to weeks after dose reduction or discontinuation |
| Mycophenolate mofetil | Inhibits lymphocyte proliferation | Cytomegalovirus, herpes simplex virus reactivation; bacterial infections | Days to weeks |
| Methotrexate | Antiproliferative; mild immunosuppression at low doses | Opportunistic infections at higher doses; Pneumocystis jirovecii; herpes zoster | Days to weeks |
| JAK inhibitors (tofacitinib, baricitinib) | Inhibit cytokine signaling; impair T-cell and natural killer cell function | Herpes zoster (markedly increased risk); opportunistic infections; tuberculosis | Days to weeks |
| Alemtuzumab | Profound and prolonged T-cell and B-cell depletion | Pneumocystis jirovecii, cytomegalovirus, fungal infections; requires prolonged prophylaxis | Months to years for full immune reconstitution |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Recurrent sinopulmonary infections + autoimmune cytopenia | Common variable immunodeficiency | Check immunoglobulin levels and B-cell subsets |
| Recurrent meningococcal meningitis | Terminal complement deficiency | Order CH50 and AP50; if low, order individual complement levels |
| Hepatic and pulmonary abscesses with Staphylococcus aureus or Aspergillus | Chronic granulomatous disease | Order dihydrorhodamine flow cytometry or nitroblue tetrazolium test |
| Pneumocystis jirovecii pneumonia in adult without HIV | Severe T-cell defect or immunosuppressive medication | Check CD4 count; review medications; consider primary combined immunodeficiency |
| Eczema + thrombocytopenia + recurrent infections in male | Wiskott-Aldrich syndrome | Check platelet size (small); genetic testing for WAS gene |
| Ataxia + telangiectasias + sinopulmonary infections | Ataxia-telangiectasia | Check alpha-fetoprotein (elevated); ATM gene testing |
| Recurrent “cold” abscesses + severe eczema + coarse facies | Hyper-immunoglobulin E syndrome | Check serum immunoglobulin E level (usually greater than 2,000 IU/mL); STAT3 gene testing |
| Absent tonsils and lymph nodes in male with recurrent bacterial infections | X-linked agammaglobulinemia | Check immunoglobulins (absent or very low); B-cell count (absent); BTK gene testing |
| Recurrent infections + oral ulcers cycling every 3 weeks | Cyclic neutropenia | Serial complete blood counts twice weekly for 6 weeks to document cycling |
| Overwhelming sepsis with encapsulated bacteria after splenectomy | Overwhelming post-splenectomy infection | Immediate empiric antibiotics; blood cultures; ensure vaccination status |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
Tiered Approach to Investigation:
- Tier 1 (Initial Screening): Complete blood count with differential, comprehensive metabolic panel, HIV testing, quantitative immunoglobulins — appropriate for all patients with suspected immunodeficiency
- Tier 2 (Directed Testing): Based on infection pattern and Tier 1 results — complement studies, vaccine responses, lymphocyte subsets, phagocyte function tests
- Tier 3 (Specialized Testing): Genetic testing, advanced flow cytometry, specialized functional assays — typically ordered by or in consultation with immunology
Tier 1: Initial Screening for All Patients
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Complete blood count with differential | Screen for cytopenias, neutropenia, lymphopenia | Neutropenia (absolute neutrophil count less than 1,500 cells/μL); lymphopenia (less than 1,000 cells/μL in adults); thrombocytopenia | Small platelets in Wiskott-Aldrich syndrome; Howell-Jolly bodies suggest asplenia; serial counts may be needed for cyclic neutropenia |
| Peripheral blood smear | Assess cell morphology; detect Howell-Jolly bodies | Howell-Jolly bodies (asplenia); abnormal lymphocyte morphology; small platelets | Request specifically if asplenia suspected; automated differentials may miss morphologic abnormalities |
| Comprehensive metabolic panel | Screen for diabetes, renal failure, liver disease | Elevated glucose; elevated creatinine; elevated liver enzymes; low albumin | Low albumin may indicate protein loss (nephrotic syndrome, protein-losing enteropathy) |
| HIV 1 and 2 antigen/antibody test | Screen for HIV infection | Positive result; if positive, obtain CD4 count and viral load | Fourth-generation testing preferred; consider RNA testing if acute infection suspected and antibody negative |
| Quantitative immunoglobulins (IgG, IgA, IgM) | Screen for antibody deficiency | Low IgG (less than 600 mg/dL significant); absent IgA (less than 7 mg/dL); low IgM | IgG less than 400 mg/dL usually requires replacement; very low IgA increases transfusion reaction risk; check during infection-free period if possible |
| Serum protein electrophoresis | Screen for myeloma, monoclonal gammopathy, hypogammaglobulinemia | Absent gamma peak (agammaglobulinemia); monoclonal spike (myeloma, chronic lymphocytic leukemia) | May reveal secondary cause of hypogammaglobulinemia; follow with immunofixation if monoclonal protein suspected |
| Urinalysis with protein quantification | Screen for nephrotic syndrome | Proteinuria; if present, quantify with spot protein-to-creatinine ratio or 24-hour urine | Nephrotic range proteinuria causes urinary immunoglobulin loss |
Tier 2: Directed Testing Based on Clinical Pattern
If Suspecting Antibody Deficiency
First-Line Tests
- IgG subclasses (IgG1, IgG2, IgG3, IgG4): IgG2 deficiency associated with poor polysaccharide responses; interpret with caution as isolated subclass deficiency controversial
- Vaccine response titers (pre and post): Check titers to tetanus and diphtheria (protein antigens) and pneumococcal serotypes (polysaccharide antigens); inadequate response confirms functional antibody deficiency
- Isohemagglutinins (anti-A, anti-B): Natural antibodies to blood group antigens; absent in agammaglobulinemia and some common variable immunodeficiency patients (not valid in blood type AB)
Second-Line Tests
- B-cell quantification (CD19 or CD20): Absent B cells in X-linked agammaglobulinemia; may be low or normal in common variable immunodeficiency
- B-cell subset analysis: Switched memory B cells often reduced in common variable immunodeficiency; helps classify and predict complications
- Genetic testing: BTK gene for X-linked agammaglobulinemia; various genes for common variable immunodeficiency phenotype
If Suspecting Complement Deficiency
First-Line Tests
- CH50 (total hemolytic complement): Screens classical pathway; will be zero or very low if any component C1-C9 is absent; normal result does not exclude mannose-binding lectin or alternative pathway defects
- AP50 (alternative pathway hemolytic assay): Screens alternative pathway (factors B, D, properdin, C3, C5-C9); order if CH50 normal but complement deficiency suspected
Second-Line Tests
- Individual complement component levels: Order C3, C4 initially; if CH50 zero, measure each component (C1q, C2, C3, C4, C5, C6, C7, C8, C9) to identify specific deficiency
- Mannose-binding lectin level: If recurrent infections in early childhood; clinical significance in adults is limited
- Genetic testing: Confirms specific complement deficiency; important for family screening
If Suspecting Phagocyte Defect
First-Line Tests
- Dihydrorhodamine (DHR) flow cytometry: Gold standard for chronic granulomatous disease; measures oxidative burst; absent or reduced fluorescence indicates chronic granulomatous disease
- Absolute neutrophil count (serial): Twice weekly for 6 weeks to document cyclic neutropenia; nadir typically less than 200 cells/μL
Second-Line Tests
- CD18 expression (flow cytometry): Absent or reduced in leukocyte adhesion deficiency type 1
- Myeloperoxidase staining: Absent in myeloperoxidase deficiency (usually mild clinical phenotype)
- Genetic testing: CYBB, NCF1, NCF2 for chronic granulomatous disease; ELANE for cyclic and severe congenital neutropenia
If Suspecting T-Cell or Combined Deficiency
First-Line Tests
- Lymphocyte subset analysis (CD3, CD4, CD8, CD19, CD16/56): Quantifies T cells, helper T cells, cytotoxic T cells, B cells, and natural killer cells; low CD4 count indicates T-cell deficiency
- CD4 count: If HIV positive; less than 200 cells/μL indicates AIDS; guides prophylaxis and opportunistic infection risk
Second-Line Tests
- T-cell proliferation assays: Response to mitogens (phytohemagglutinin, concanavalin A) and antigens (Candida, tetanus); assesses T-cell function
- T-cell receptor excision circles (TRECs): Marker of recent thymic emigrants; used in newborn screening for severe combined immunodeficiency
- Genetic testing: IL2RG (X-linked severe combined immunodeficiency), JAK3, RAG1/2, and others based on phenotype
Assessing Vaccine Responses
Protocol for Vaccine Response Testing
Vaccine responses are the most important functional test of antibody immunity. Poor responses confirm clinical significance of low immunoglobulin levels.
- Step 1: Check baseline titers to tetanus, diphtheria, and pneumococcal serotypes (at least 14 serotypes)
- Step 2: If titers are low, administer Tdap vaccine and 23-valent pneumococcal polysaccharide vaccine (PPSV23)
- Step 3: Recheck titers 4 to 6 weeks after vaccination
- Step 4: Interpret results:
- Tetanus and diphtheria: protective titer generally greater than 0.1 IU/mL
- Pneumococcal: adequate response defined as protective titers (greater than 1.3 μg/mL) to more than 70% of serotypes tested, or at least 2-fold rise in more than 70% of serotypes
Note: Do not administer live vaccines until immunodeficiency has been evaluated and severe T-cell defects excluded.
Imaging Studies
| Study | Indications | What to Look For |
|---|---|---|
| Chest radiograph | All patients with recurrent respiratory infections | Bronchiectasis; absent thymic shadow (severe combined immunodeficiency); hilar adenopathy |
| High-resolution chest computed tomography | Suspected bronchiectasis; interstitial lung disease; granulomatous disease | Bronchiectasis (dilated airways, signet ring sign); ground-glass opacities; nodules; granulomas |
| Computed tomography of sinuses | Recurrent sinusitis; chronic symptoms | Mucosal thickening; opacification; polyps; anatomic abnormalities |
| Abdominal ultrasound or computed tomography | Hepatosplenomegaly; suspected abscesses | Spleen size and presence; liver abscesses (chronic granulomatous disease); lymphadenopathy |
| Nuclear medicine spleen scan | Suspected functional asplenia | Absent or reduced splenic uptake confirms functional asplenia |
Special Investigations for Specific Conditions
| Suspected Condition | Key Diagnostic Tests | Expected Findings |
|---|---|---|
| Hyper-immunoglobulin E syndrome | Serum IgE level; eosinophil count; STAT3 gene testing | IgE typically greater than 2,000 IU/mL (often greater than 10,000); eosinophilia; STAT3 mutation confirms autosomal dominant form |
| Ataxia-telangiectasia | Alpha-fetoprotein; immunoglobulins; ATM gene testing | Elevated alpha-fetoprotein (greater than 10 ng/mL); low IgA and IgG2; ATM gene mutations |
| Wiskott-Aldrich syndrome | Platelet count and volume; immunoglobulins; WAS gene testing | Thrombocytopenia with small platelets (mean platelet volume less than 7 fL); low IgM, elevated IgA and IgE; WAS gene mutation |
| DiGeorge syndrome | Fluorescent in situ hybridization or chromosomal microarray for 22q11.2; calcium; echocardiogram | 22q11.2 deletion; hypocalcemia; conotruncal cardiac defects |
| Severe combined immunodeficiency | Lymphocyte subsets; T-cell receptor excision circles; genetic testing | Absent or very low T cells (often less than 300 cells/μL); absent TRECs; specific gene mutation identifies subtype |
When to Refer to Immunology
Referral Indications
- Confirmed hypogammaglobulinemia (IgG less than 400 mg/dL) or suspected antibody deficiency with poor vaccine responses
- Suspected primary immunodeficiency requiring specialized testing or genetic evaluation
- Need for immunoglobulin replacement therapy
- Recurrent infections despite negative initial workup
- Opportunistic infections without clear secondary cause
- Family history of primary immunodeficiency
- Abnormal newborn screening for severe combined immunodeficiency
- Complex cases requiring multidisciplinary management
Diagnostic Algorithm Summary
| If Initial Workup Shows | Next Steps | Consider Referral If |
|---|---|---|
| Low immunoglobulins | Vaccine responses; B-cell quantification; rule out secondary causes (myeloma, chronic lymphocytic leukemia, protein loss) | IgG less than 400 mg/dL; poor vaccine responses; need for replacement therapy |
| Normal immunoglobulins but recurrent bacterial infections | Vaccine responses; IgG subclasses; complement studies (CH50, AP50); imaging of affected sites | Poor vaccine responses; complement deficiency confirmed; anatomical cause excluded |
| Neutropenia | Serial counts for cyclic pattern; bone marrow biopsy; autoimmune workup | Severe congenital neutropenia; cyclic neutropenia confirmed; cause unclear |
| Lymphopenia | HIV testing; lymphocyte subsets; consider secondary causes (corticosteroids, malignancy) | Low CD4 count without HIV; suspected combined immunodeficiency |
| Recurrent abscesses with Staphylococcus aureus or fungi | Dihydrorhodamine flow cytometry for chronic granulomatous disease; IgE level for hyper-IgE syndrome | Chronic granulomatous disease confirmed; hyper-IgE syndrome suspected |
| Recurrent Neisseria infections | CH50 (should be zero in terminal complement deficiency); individual complement levels | Complement deficiency confirmed (for vaccination counseling and family screening) |
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Active severe infection (sepsis, meningitis, pneumonia with respiratory failure) | EMERGENT | Stabilize patient; obtain cultures; start broad-spectrum antibiotics immediately; defer immunologic workup until stable |
| Suspected Pneumocystis jirovecii pneumonia or other opportunistic infection | EMERGENT | Obtain induced sputum or bronchoscopy; start empiric treatment; urgent HIV testing and CD4 count |
| Asplenic patient with fever | EMERGENT | Blood cultures; immediate empiric antibiotics covering encapsulated organisms (ceftriaxone); do not wait for results |
| Infant with failure to thrive and recurrent infections | URGENT | Urgent lymphocyte subsets; avoid live vaccines; expedited immunology referral for possible severe combined immunodeficiency |
| New diagnosis of hypogammaglobulinemia with active infection | URGENT | Treat active infection aggressively; consider urgent immunoglobulin replacement if IgG very low; immunology referral within days |
| Recurrent sinopulmonary infections without current severe illness | ROUTINE | Outpatient workup; initial screening tests; immunology referral if abnormal results; target workup completion within 4-6 weeks |
| History of recurrent infections, currently well | ROUTINE | Comprehensive history review; outpatient laboratory workup; elective subspecialty referral based on findings |
Step 2: Classify by Infection Pattern
Sinopulmonary Pattern
Recurrent sinusitis, otitis, bronchitis, pneumonia
Primary consideration: Antibody deficiency
Proceed to Algorithm A
Opportunistic Pattern
Pneumocystis jirovecii, Candida, Cryptococcus, cytomegalovirus, mycobacteria
Primary consideration: T-cell or combined deficiency
Proceed to Algorithm B
Pyogenic/Abscess Pattern
Deep abscesses, osteomyelitis, severe skin infections
Primary consideration: Phagocyte defect or hyper-immunoglobulin E syndrome
Proceed to Algorithm C
Step 3: Follow the Appropriate Algorithm
Algorithm A: Sinopulmonary Infection Pattern
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Recurrent bacterial sinusitis and pneumonia; low IgG, IgA, and/or IgM | Common variable immunodeficiency | Check vaccine responses; B-cell subsets; refer to immunology for immunoglobulin replacement |
| Recurrent infections; IgA less than 7 mg/dL with normal IgG and IgM | Selective immunoglobulin A deficiency | Most are asymptomatic; check vaccine responses if symptomatic; warn about transfusion reactions |
| Recurrent infections; normal immunoglobulin levels; poor vaccine responses | Specific antibody deficiency | Document poor response to pneumococcal vaccine; consider antibiotic prophylaxis or immunoglobulin replacement if severe |
| Male patient; absent immunoglobulins; no B cells; absent tonsils | X-linked agammaglobulinemia | Genetic testing (BTK gene); lifelong immunoglobulin replacement; avoid live vaccines |
| Recurrent infections; hypogammaglobulinemia; monoclonal protein or lymphocytosis | Secondary antibody deficiency (chronic lymphocytic leukemia, myeloma) | Hematology referral; treat underlying malignancy; consider immunoglobulin replacement |
Algorithm B: Opportunistic Infection Pattern
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Pneumocystis jirovecii pneumonia; oral candidiasis; risk factors present | HIV infection | Confirm with HIV testing; CD4 count; start antiretroviral therapy; opportunistic infection prophylaxis |
| Opportunistic infections; on immunosuppressive medications | Iatrogenic immunosuppression | Reduce immunosuppression if possible; appropriate prophylaxis; treat active infection |
| Opportunistic infections; low CD4 count; HIV negative; no immunosuppressive medications | Idiopathic CD4 lymphocytopenia or primary combined immunodeficiency | Lymphocyte subsets; genetic testing; lifelong monitoring; consider prophylaxis |
| Disseminated mycobacterial infection (including non-tuberculous mycobacteria or BCG) | Interferon-gamma/interleukin-12 pathway defect | Specific pathway testing; genetic testing; interferon-gamma therapy may be indicated |
| Infant with opportunistic infections; lymphopenia; failure to thrive | Severe combined immunodeficiency | Urgent lymphocyte subsets and genetic testing; avoid live vaccines; refer for hematopoietic stem cell transplant evaluation |
Algorithm C: Pyogenic/Abscess Pattern
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Deep abscesses (liver, lung, lymph node); Staphylococcus aureus, Aspergillus, Serratia | Chronic granulomatous disease | Dihydrorhodamine flow cytometry; genetic testing; prophylactic antibiotics and antifungals; interferon-gamma therapy |
| “Cold” abscesses; severe eczema; coarse facies; elevated immunoglobulin E | Hyper-immunoglobulin E syndrome | Check IgE level; STAT3 gene testing; prophylactic antibiotics; aggressive treatment of infections |
| Recurrent skin infections; very high neutrophil count; delayed cord separation | Leukocyte adhesion deficiency | CD18 expression by flow cytometry; genetic testing; consider hematopoietic stem cell transplant |
| Recurrent infections and oral ulcers every 3 weeks; cyclic neutropenia on serial counts | Cyclic neutropenia | Document with serial complete blood counts; granulocyte colony-stimulating factor therapy; genetic testing (ELANE gene) |
| Recurrent abscesses; diabetes mellitus present | Diabetes-associated immune dysfunction | Optimize glycemic control; rule out additional immunodeficiency if infections very severe |
Algorithm D: Recurrent Meningitis or Neisseria Infections
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Two or more episodes of meningococcal meningitis | Terminal complement deficiency (C5-C9) | CH50 (will be zero); individual complement levels; meningococcal vaccination; antibiotic prophylaxis; family screening |
| Recurrent meningitis; cerebrospinal fluid leak identified | Anatomical defect (skull base fracture, cribriform plate defect) | High-resolution computed tomography of skull base; surgical repair; pneumococcal vaccination |
| Recurrent meningitis with encapsulated organisms; history of splenectomy | Asplenia | Confirm with blood smear (Howell-Jolly bodies); vaccination; antibiotic prophylaxis; patient education about fever |
| Recurrent meningitis; systemic lupus erythematosus-like illness | Early complement deficiency (C1, C2, C4) | CH50; C3, C4 levels; individual early component levels; manage lupus-like illness |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient has IgG less than 200 mg/dL | Treat any active infection aggressively; contact immunology urgently | Likely needs immunoglobulin replacement; exclude secondary causes (myeloma, chronic lymphocytic leukemia) |
| Patient has IgG 200-400 mg/dL | Check vaccine responses; assess infection severity | Immunology referral; replacement therapy if poor vaccine responses and significant infections |
| Patient has IgG 400-600 mg/dL with recurrent infections | Check vaccine responses before assuming deficiency is the cause | If vaccine responses normal, look for other causes; if poor responses, consider specific antibody deficiency |
| CH50 is zero | Patient has complete deficiency of a complement component | Measure individual components (C1-C9) to identify specific deficiency; vaccinate against encapsulated organisms; family screening |
| Dihydrorhodamine test shows absent oxidative burst | Confirms chronic granulomatous disease | Genetic testing; start prophylactic trimethoprim-sulfamethoxazole and itraconazole; refer for consideration of interferon-gamma and transplant |
| HIV test is positive | Confirm with supplemental testing; obtain CD4 count and viral load | Start antiretroviral therapy; prophylaxis based on CD4 count; treat opportunistic infections |
| Patient needs surgery and has suspected immunodeficiency | Optimize infection control; consider perioperative antibiotics; immunoglobulin replacement if indicated | Expedite immunologic workup; coordinate with immunology for perioperative management |
| Patient with immunodeficiency needs vaccination | Killed vaccines are safe; avoid live vaccines until T-cell defects excluded | Vaccinate household contacts; live vaccines contraindicated in severe T-cell defects and during immunoglobulin replacement |
| Asplenic patient presents with fever | Blood cultures immediately; empiric ceftriaxone within 1 hour; do not wait | Admit for observation even if appears well; overwhelming post-splenectomy infection can progress rapidly |
| Patient on immunoglobulin replacement still having infections | Check trough IgG level; review infection types | Target trough greater than 800-1000 mg/dL; consider additional prophylaxis; evaluate for bronchiectasis or anatomical problems |
Troubleshooting: When Initial Workup Is Negative
Ask These Questions
- Are the infections truly abnormal? — Consider normal infection frequency for age, exposures (daycare, healthcare work), and environment
- Is there an anatomical cause? — Image the site of recurrent infection; consider bronchiectasis, sinus polyps, urinary tract abnormalities, cerebrospinal fluid leak
- Were vaccine responses checked? — Normal immunoglobulin levels do not exclude specific antibody deficiency; always check functional responses
- Was complement evaluated? — Complement deficiency often missed; CH50 should be zero, not just low, in complete deficiency
- Is there occult HIV infection? — Consider repeat testing if high-risk; check for acute infection if initial antibody test was early
- Are there secondary causes? — Diabetes, malignancy, protein-losing states, medications may not have been fully evaluated
- Should specialized testing be done? — Consider immunology referral for advanced functional assays, natural killer cell function, cytokine responses
- Is the diagnosis correct? — Reconsider whether infections were truly present; some patients have recurrent inflammatory symptoms without infection
Management Principles by Diagnosis
| Diagnosis | Primary Management | Prophylaxis | Monitoring |
|---|---|---|---|
| Common variable immunodeficiency | Immunoglobulin replacement (intravenous or subcutaneous) | Target trough IgG greater than 800 mg/dL; some need additional antibiotics | Trough IgG levels; annual pulmonary function tests; watch for autoimmune complications and malignancy |
| Chronic granulomatous disease | Prophylactic trimethoprim-sulfamethoxazole and itraconazole; interferon-gamma | Lifelong antimicrobial prophylaxis essential | Regular imaging for occult infection; consider hematopoietic stem cell transplant in severe cases |
| Complement deficiency | No replacement available; vaccination and prophylaxis | Meningococcal, pneumococcal, Haemophilus influenzae type b vaccines; consider penicillin prophylaxis | Education about early signs of infection; medical alert identification |
| Asplenia | Vaccination; patient education; antibiotic prophylaxis | Penicillin or amoxicillin daily (especially first 2 years and in children); lifelong in high-risk patients | Ensure vaccinations current; emergency antibiotics at home; medical alert identification |
| HIV infection | Antiretroviral therapy | Based on CD4 count: Pneumocystis jirovecii (less than 200), Mycobacterium avium complex (less than 50), others as indicated | CD4 count and viral load; discontinue prophylaxis when CD4 recovers |
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Secondary causes are far more common than primary: In adults, always exclude HIV, diabetes, medications, malignancy, and anatomical factors before pursuing primary immunodeficiency workup. Secondary immunodeficiency accounts for the vast majority of cases.
The organism tells you the defect: Encapsulated bacteria suggest antibody or complement deficiency; catalase-positive organisms suggest chronic granulomatous disease; opportunistic fungi and viruses suggest T-cell defects. Let the pathogen guide your workup.
Normal immunoglobulin levels do not exclude antibody deficiency: Specific antibody deficiency presents with normal quantitative immunoglobulins but poor functional responses to vaccines. Always check vaccine response titers in suspected antibody deficiency.
CH50 should be zero in complement deficiency: A complete deficiency of any component C1-C9 results in CH50 of zero, not just a low value. A mildly low CH50 usually reflects consumption (infection, autoimmune disease) rather than genetic deficiency.
Think recurrent Neisseria, think complement: Any patient with two or more episodes of meningococcal disease or disseminated gonococcal infection should be evaluated for terminal complement deficiency, regardless of how healthy they appear otherwise.
Asplenic patients need immediate antibiotics for fever: Overwhelming post-splenectomy infection can progress from mild symptoms to death within hours. Empiric antibiotics should be given within one hour of presentation — do not wait for culture results.
Common variable immunodeficiency is not just infections: Approximately 25% of patients develop autoimmune complications (cytopenias, inflammatory bowel disease-like illness), and there is increased risk of lymphoma and gastric cancer. These patients need comprehensive long-term monitoring.
Absent tonsils and lymph nodes are a clue: In X-linked agammaglobulinemia, B cells are absent, so there is no lymphoid tissue development. Small or absent tonsils and impalpable lymph nodes in a male with recurrent bacterial infections should prompt immediate immunoglobulin measurement and B-cell quantification.
Critical Pitfalls to Avoid
Failing to test for HIV: HIV infection is the most common cause of acquired immunodeficiency worldwide. It should be tested in every patient presenting with recurrent or opportunistic infections, regardless of perceived risk factors. Many patients are diagnosed late due to failure to test.
Giving live vaccines before excluding severe immunodeficiency: Live vaccines (measles-mumps-rubella, varicella, yellow fever, oral polio, BCG) can cause disseminated and fatal infection in patients with severe T-cell defects. Never give live vaccines until significant immunodeficiency has been excluded.
Dismissing recurrent infections as “just bad luck”: While some patients do have normal infection frequency, a careful history often reveals that infections are more severe, more frequent, or caused by unusual organisms. Document infections carefully and maintain a low threshold for workup.
Forgetting to ask about medications: Corticosteroids, tumor necrosis factor inhibitors, rituximab, and many other medications cause significant immunosuppression. Always obtain a complete medication history including recent medications that may have been stopped.
Ignoring anatomical causes: Recurrent infections at a single site often have an anatomical explanation (bronchiectasis, sinus polyps, urinary obstruction, cerebrospinal fluid leak). Image the site of recurrent infection before attributing all infections to immunodeficiency.
Stopping immunoglobulin replacement too soon: Primary antibody deficiencies are lifelong conditions. Stopping immunoglobulin replacement, even if the patient has been infection-free, leads to recurrence of infections and potential permanent organ damage.
Missing protein-losing states: Nephrotic syndrome and protein-losing enteropathy can cause secondary hypogammaglobulinemia through urinary or gastrointestinal loss of immunoglobulins. Check albumin and urine protein in patients with unexplained low immunoglobulins.
Delaying workup during active infection: While some tests may be affected by acute illness, basic screening (complete blood count, immunoglobulins, HIV testing) can and should be obtained during acute infection. Delaying all workup means missing opportunities for diagnosis.
Key Takeaways
- Recurrent infections warrant systematic evaluation: characterize by site, organism, severity, frequency, and response to treatment to guide workup
- Secondary immunodeficiency (HIV, diabetes, medications, malignancy) is far more common than primary immunodeficiency in adults — always exclude these first
- The pattern of infections suggests the immune defect: sinopulmonary bacterial infections suggest antibody deficiency; opportunistic infections suggest T-cell defects; deep abscesses with Staphylococcus aureus and Aspergillus suggest chronic granulomatous disease
- Initial workup includes complete blood count with differential, comprehensive metabolic panel, HIV testing, and quantitative immunoglobulins — these simple tests identify most cases
- Vaccine response testing is essential when immunoglobulin levels are normal but antibody deficiency is suspected; poor responses to polysaccharide vaccines confirm functional deficiency
- Complement deficiency should be suspected with recurrent Neisseria infections — CH50 will be zero (not just low) in complete deficiency of any classical pathway component
- Asplenic patients are at lifelong risk of overwhelming post-splenectomy infection; fever requires immediate empiric antibiotics and should never be observed without treatment
- Avoid live vaccines until severe T-cell defects have been excluded; killed vaccines are safe in all immunodeficiency states
- Early referral to immunology is appropriate for confirmed hypogammaglobulinemia, suspected primary immunodeficiency, need for immunoglobulin replacement, or complex cases with negative initial workup
- Long-term management of primary immunodeficiency requires regular monitoring for complications including bronchiectasis, autoimmune disease, and malignancy in addition to infection prevention
Quick Reference Algorithm
Systematic Approach to Recurrent Infections:
- Confirm infections are abnormal: Document frequency, severity, organisms, and sites; apply the “SPUR” criteria (Severe, Persistent, Unusual, Recurrent)
- Exclude secondary causes: HIV testing, glucose, creatinine, medication review, age-appropriate cancer screening; these account for most adult cases
- Check for anatomical factors: Image the site of recurrent infection; look for bronchiectasis, obstruction, foreign bodies, or structural defects
- Obtain initial immune screening: Complete blood count with differential, quantitative immunoglobulins (IgG, IgA, IgM), and review peripheral smear
- Pursue directed testing based on pattern: Vaccine responses for suspected antibody deficiency; CH50 and AP50 for recurrent Neisseria or meningitis; dihydrorhodamine flow cytometry for recurrent abscesses; lymphocyte subsets for opportunistic infections
- Refer to immunology: For confirmed immunodeficiency, need for replacement therapy, or persistent recurrent infections despite negative initial workup
- Implement preventive measures: Vaccination (killed vaccines safe in all; live vaccines require caution), antibiotic prophylaxis when indicated, immunoglobulin replacement for antibody deficiency
- Establish long-term monitoring: Watch for end-organ damage (bronchiectasis), autoimmune complications, and malignancy in primary immunodeficiency; ensure ongoing adherence to prophylaxis